Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer. (Q54113079)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer. |
scientific article |
Statements
Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer (English)
J O'Shaughnessy
G N Hortobagyi
S M Stemmer
H A Burris
S Paluch-Shimon
M Campone
K Petrakova
K L Blackwell
W Janni
S Verma
P Conte
C L Arteaga
D A Cameron
S Mondal
F Su
M Miller
M Elmeliegy